Article
Targeting netrin‐3 in small cell lung cancer and neuroblastoma
15 Mar 2021
Abstract excerpt
The navigation cue netrin-1 is well-documented for its key role in cancer development and represents a promising therapeutic target currently under clinical investigation. Phase 1 and 2 clinical trials are ongoing with NP137, a humanized monoclonal antibody against netrin-1. Interestingly, the epitope recognized by NP137 in netrin-1 shares 90% homology with its counterpart in netrin-3, the closest member to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
